RevBio is a clinical stage medical device company engaged in the development and commercialization of TETRANITE®, a patented, synthetic, injectable, self-setting, load-bearing, and osteoconductive bone adhesive biomaterial that bonds bone to bone and bone to metal
RevBio is a clinical stage medical device company engaged in the development and commercialization of TETRANITE®, a patented, synthetic, injectable, self-setting, load-bearing, and osteoconductive bone adhesive biomaterial that bonds bone to bone and bone to metal.
RevBio is a clinical stage medical device company engaged in the development and commercialization of TETRANITE®, a patented, synthetic, injectable, self-setting, load-bearing, and osteoconductive bone adhesive biomaterial that bonds bone to bone and bone to metal
RevBio is a clinical stage medical device company engaged in the development and commercialization of TETRANITE®, a patented, synthetic, injectable, self-setting, load-bearing, and osteoconductive bone adhesive biomaterial that bonds bone to bone and bone to metal.